Navigation Links
Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharma's Scientific and Medical Advisory Board
Date:5/25/2011

LOS ANGELES, May 25, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cancer therapies, today announced that Patrick Hwu, M.D., and Mario Sznol, M.D., have joined the Company's recently formed Scientific and Medical Advisory Board (SMAB).

Dr. Hwu is currently on the faculty of the University of Texas MD Anderson Cancer Center in Houston, and serves as chairman of the Center's Department of Melanoma Medical Oncology, Division of Cancer Medicine.

Dr. Sznol is currently on the faculty of Yale University School of Medicine, and is Professor of Medicine (Medical Oncology), and also serves as Vice-Chief Medical Oncology and Co-Director of the Yale Cancer Center Melanoma Program.

"We are pleased that Drs. Hwu and Sznol have joined our new Scientific and Medical Advisory Board, and look forward to their contribution in helping to guide our autologous cell therapy program," said Anthony J. Cataldo, President and Chief Executive Officer.

Drs. Hwu and Sznol join other leading oncologists and cancer researchers on the prestigious Genesis Biopharma SMAB who include: Cassian Yee, M.D., Professor of Medicine at the University of Washington's Fred Hutchinson Cancer Research Center; James Mule, Ph.D., and Jeffrey Weber, M.D., Ph.D., of the H. Lee Moffitt Cancer Center & Research Institute; David DiGiusto, Ph.D., of the City of Hope; and Daniel Powell, Ph.D., from the University of Pennsylvania School of Medicine.

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer therapies.  For more information about the company, visit www.genesis-biopharma.com.

Forward-Looking Statements

The foregoing press announcement contains forward-looking statements that can be identified by such terminology as "expect," "potential," "suggests," "bodes," "may," "should," "could" or similar expressions.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.  In particular, management's expectations regarding future research, development and/or commercial results could be affected by, among other things, uncertainties relating to clinical trials and product development; availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general. Forward-looking statements speak only as of the date they are made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


'/>"/>
SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM)
2. Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders
3. Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders
4. Healthcare Distribution Management Association Names Patrick Kelly New Senior Vice President, Government Affairs
5. Patrick Dempsey Teams up With Breakaway from CancerĀ® to Help Connect Cancer Patients to Free Resources
6. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
7. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
8. Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors
9. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
10. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
11. Cerimon Pharmaceuticals Appoints James S. Shannon, M.D., to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... May 20, 2017 , ... ... the lengthy trial and error process by finding the right antidepressant faster. ... strengthen the doctor-patient relationship through a personalized approach to treatment. , ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... ... procedure on April 28, 2017 at the Prince Of Wales Private Hospital. The ... disc at level C6-C7. The patient failed conservative treatments prior to undergoing surgery. ...
(Date:5/18/2017)... , ... May 17, 2017 , ... NDA Partners Chairman ... and former CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit ... his position at Eurofins and Cardinal Health, he was former Chief Operating Officer at ...
(Date:5/18/2017)... ... May 17, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, is honored that Jay Crowley ... conference in Brussels, Belgium. , Crowley played a crucial role in the development ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):